Retrieve Medical (RMHI) 10-Q2016 Q1 Quarterly report

Filed: 18 Feb 16, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: alter, approximate, Codification, Commission, committee, complex, complied, comprehensive, COSO, defined, difficult, discontinued, discontinuing, employ, employee, equipment, establishment, expert, extending, flow, formal, framework, fund, hierarchy, highest, highly, identical, impaired, impairment, imposition, independent, ineffective, initially, Joint, judgment, landlord, life, liquid, lived, LLC, longed, lowest, maturity, member, monitoring, mutual, NDA, notice, November, observable, oversight, person, possession, predict, prioritizing, priority, properly, quoted, short, size, Specifically, Sponsoring, standard, transfer, transmission, Treadway, typically, undiscounted, unobservable, vacate, valuation, Venture, view, waive, York

Removed: accrued, annum, assumption, attending, automatic, breakdown, bring, calculating, calendar, charge, Commencing, commitment, committed, consulting, convertible, credited, decided, dedicated, direction, endeavor, ending, entrance, entry, equal, event, extension, extinguishment, February, fifteen, Frac, gain, generating, guaranteed, industry, investor, January, June, minimum, monthly, moving, obligation, oilfield, paid, percent, proceed, profit, profitability, project, proposed, relate, satisfy, sufficient, Technology, twelve, verifiable, waste, web

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

RMHI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Peak Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2015 (the “Report”), I, Arnold Tinter, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and

2) The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations.

Date: February 18, 2016

/s/ Arnold Tinter, Chief Executive Officer